Phase I studies include the first introduction of an investigational new drug into humans.
They are primarily concerned with evaluating the safety profile of the drug and are designed to determine:
- The metabolism and pharmacologic actions of the drugs in humans
- The side effects associated with increasing doses
The safety aspects of the drug are usually assessed by obtaining multiple blood and serum samples.